How can the stigma surrounding cannabis use impact the accessibility of cannabinoid therapies?
How can the stigma surrounding cannabis use impact the accessibility of cannabinoid therapies? The stigma surrounding cannabis use can significantly impact the accessibility of cannabinoid therapies by influencing public perceptions, healthcare provider attitudes, and policy frameworks. Negative perceptions of cannabis can deter patients from seeking cannabinoid treatments, even when they may benefit from them. Healthcare providers may also hesitate to recommend cannabinoid therapies due to concerns about legal implications or professional repercussions. Additionally, stigma can shape policy decisions that restrict access to cannabinoid products, limiting availability for patients in need. Addressing stigma through education and awareness campaigns is essential to improve access to cannabinoid therapies and promote their legitimate therapeutic use (Zolotarev et al., 2022).